Myron S. Cohen, MD, FIDSA, is the Yeargan-Bate Eminent Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina at Chapel Hill and director of the UNC Institute for Global Health and Infectious Disease. Dr. Cohen is a fellow of IDSA, the American College of Physicians and the American Society for Microbiology. He is a member of the National Academy of Medicine, the American Society of Clinical Investigation and the American Association of Physicians.  Dr. Cohen’s research has focused on the transmission and prevention of transmission of infectious diseases. Dr. Cohen is the architect and principal investigator of the multinational HPTN 052 trial, which proved that antiretroviral treatment of people with HIV infection prevents the sexual transmission of the virus. This work was recognized by the journal Science as the “Breakthrough of the Year” in 2011. With the onset of the COVID-19 pandemic in 2020, Dr. Cohen was appointed to the Leadership Committee of the NIH COVID Prevention Network (CoVPN). Dr. Cohen has focused on monoclonal antibodies for prevention of COVID-19, leading a variety of studies and collaborations. Dr. Cohen is the author of more than 600 publications and one book.